CompletedNot Applicable

TACAD Program for Asian American Family Caregivers of Persons Living With Alzheimer's Disease

United States54 participantsStarted 2024-04-05

Plain-language summary

The purpose of the proposed study is to preliminarily evaluate Technology-based information and coaching/support program that is tailored for Asian American midlife women who are family caregivers of patients living with Alzheimer's disease (TACAD) in improving health outcomes of Asian American midlife women who are family caregivers of persons living with Alzheimer's disease (AACA) and their care recipients.

Who can participate

Age range40 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * self reported Asian American midlife women who are family caregivers of persons living with Alzheimer's disease (AACA). * Participants will be included if, by self-report, they are Asian American women aged 40 to 65 years old who identify as Chinese or Korean; * are family caregivers of PLAD; * can read and write English, Mandarin Chinese or Korean; * who reside in the U.S.; * have access to the Internet through computers or mobile devices. * Participants must be providing at least 4 hours per day unpaid assistance, on average, for a community-dwelling person in the early-middle stage of illness (Clinical Dementia Rating of 1) for whom there is no plan for institutionalization in six months. * Caregivers may or may not reside with their care recipient. Exclusion Criteria: * Those who used the AA website previously and/or participated in other studies related to AD will be excluded.

What they're measuring

Change in Multidimensional Caregiver Strain Index from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Perceived Stress Scale score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Acculturation Stress Scale (ASS) score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Social Readjustment Rating Scale (SRRS) score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Midlife Women's Symptom Index from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in EQ-5D-5L scale score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Trial details

NCT IDNCT05615233

SponsorUniversity of Texas at Austin

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-31

View on ClinicalTrials.gov More Alzheimer Disease trials

Plain-language summary

Who can participate

Age range40 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in Multidimensional Caregiver Strain Index from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Perceived Stress Scale score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Acculturation Stress Scale (ASS) score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Social Readjustment Rating Scale (SRRS) score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Midlife Women's Symptom Index from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in EQ-5D-5L scale score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention

Change in Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) score from baseline

Timeframe: Baseline, 1 months post intervention, 3 months post intervention